跳至主要内容
临床试验/NCT04427930
NCT04427930进行中(未招募)3 期

Long-Term Safety and Efficacy Extension Study Of Autologous Adipose-Derived Mesenchymal Stem Cells 『JOINTSTEM』 in Patients With Knee Osteoarthiritis: A Phase III Extension Study

R-Bio8 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2020年4月13日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
129
试验地点
8
主要终点
Adverse Events

研究概览

简要总结

The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants of Jointstem Phase 3 Clinical Trial
  • Participates who signed informed consent document of this study

排除标准

  • No applicable

结局指标

主要结局

Adverse Events

时间窗: 5 Years

Incidence of adverse events from baseline to 5 Years

次要结局

  • WOMAC 3 subscale score(5 Years)
  • SF-36(5 Years)
  • Change of Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) scores from baseline(5 Years)
  • Measuring of Kellgren-Lawrence grade(1, 2, 3, 4, 5 Years)
  • Measuring of Femoro-tibial anatomical angle(FTA)(1, 2, 3, 4, 5 Years)
  • Measuring of Hip-Knee-Ankle angle(HKA)(1, 2, 3, 4, 5 Years)
  • Measuring of Joint Space Width(1, 2, 3, 4, 5 Years)
  • MRI scan(1, 2, 3, 4, 5 Years)

研究者

发起方
R-Bio
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验